Erectile Dysfunction Drug-Patent Found Obvious

BAYER PHARMA AG, v. WATSON LABS, INC.: Nov. 1, 2017. Before Lourie, Moore, and O’Malley   Takeaway: The CAFC will reverse a finding of non-obviousness where key references are missing from a district court’s opinion and mere concerns over effectiveness do not rise to the level of teaching away. Procedural Posture: Alleged …

Federal Circuit Rules That A Substitution In The Prior Art May be Obvious Even If It Results In A Somewhat Inferior Structure

Authored by Rose Cordero Prey, Zaed M. Billah, and Ian A. Moore Digest of In re Zhang, No. 2015-1995 (Fed. Cir. June 17, 2016) (non-precedential). On appeal from P.T.A.B. Before Lourie, Dyk, and Stoll, per curiam. Procedural Posture: Appellant patentee appeals P.T.A.B.’s decision affirming patent examiner’s rejection of certain patent claims …